Palatin Technologies, Inc. (LON:0KF3)
6.50
-1.15 (-15.03%)
Oct 16, 2026, 5:12 PM GMT
Palatin Technologies Revenue
In the fiscal year ending June 30, 2026, Palatin Technologies had annual revenue of $13.19M USD. Palatin Technologies had revenue of $300.77K in the quarter ending June 30, 2026. That makes Palatin Technologies the 36,019th largest company in the world by revenue and 708th in the United Kingdom.
Revenue
$13.19M
Revenue Growth
n/a
P/S Ratio
1.04
Revenue / Employee
$527.40K
Employees
25
Market Cap
8.67M GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 13.19M | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 4.49M | -363.59K | -7.49% |
| Jun 30, 2023 | 4.85M | 3.39M | 230.53% |
| Jun 30, 2022 | 1.47M | 1.66M | - |
| Jun 30, 2021 | -188.60K | -306.59K | - |
| Jun 30, 2020 | 117.99K | -60.18M | -99.80% |
| Jun 30, 2019 | 60.30M | -6.83M | -10.18% |
| Jun 30, 2018 | 67.13M | 22.41M | 50.11% |
| Jun 30, 2017 | 44.72M | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | 12.95M | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | 10.36K | -63.38K | -85.95% |
| Jun 30, 2012 | 73.74K | -1.40M | -95.00% |
| Jun 30, 2011 | 1.48M | -12.71M | -89.60% |
| Jun 30, 2010 | 14.18M | 2.83M | 24.92% |
| Jun 30, 2009 | 11.35M | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
| Jun 30, 2006 | 19.75M | 1.79M | 9.98% |
| Jun 30, 2005 | 17.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IXICO | 7.28M |
| SkinBioTherapeutics | 5.23M |
| Fusion Antibodies | 2.11M |
| Aptamer Group | 1.54M |
| OptiBiotix Health | 1.29M |
| Oxford BioDynamics | 1.20M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 352.00K |
Palatin Technologies News
- 17 days ago - Palatin Technologies (PTN): Fiscal 2026 Revenue Inflection Comes With a Liquidity Test - AlphaStreet
- 18 days ago - Palatin Technologies Earnings Call Transcript: Q4 2026 - Transcripts
- 18 days ago - Palatin Technologies Earnings release: Q4 2026 - Filings
- 18 days ago - Palatin Technologies Annual report: Q4 2026 - Filings
- 18 days ago - Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - PRNewsWire
- 4 weeks ago - Palatin Technologies Slides: Corporate presentation - Filings
- 2 months ago - Palatin Technologies Slides: Corporate presentation - Filings
- 2 months ago - StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Newsfile Corp